These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28531230)

  • 21. Drug resistance in Plasmodium.
    Haldar K; Bhattacharjee S; Safeukui I
    Nat Rev Microbiol; 2018 Mar; 16(3):156-170. PubMed ID: 29355852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The development of artemisinin resistance in malaria: reasons and solutions.
    Chrubasik C; Jacobson RL
    Phytother Res; 2010 Jul; 24(7):1104-6. PubMed ID: 20578122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malaria resistance to non-artemisinin partner drugs: how to reACT.
    van Schalkwyk DA; Sutherland CJ
    Lancet Infect Dis; 2015 Jun; 15(6):621-3. PubMed ID: 25877961
    [No Abstract]   [Full Text] [Related]  

  • 24. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.
    Torrentino-Madamet M; Fall B; Benoit N; Camara C; Amalvict R; Fall M; Dionne P; Ba Fall K; Nakoulima A; Diatta B; Diemé Y; Ménard D; Wade B; Pradines B
    Malar J; 2014 Dec; 13():472. PubMed ID: 25471113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why the world needs another malaria initiative.
    Lancet; 2004 Jul 31-Aug 6; 364(9432):389-90. PubMed ID: 15288715
    [No Abstract]   [Full Text] [Related]  

  • 27. Artemisinin resistance: current status and scenarios for containment.
    Dondorp AM; Yeung S; White L; Nguon C; Day NP; Socheat D; von Seidlein L
    Nat Rev Microbiol; 2010 Apr; 8(4):272-80. PubMed ID: 20208550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How "resistant" is artemisinin resistant malaria? - The risks of ambiguity using the term "resistant" malaria.
    Hanscheid T; Hardisty DW
    Travel Med Infect Dis; 2018; 24():23-24. PubMed ID: 29715560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slow parasite clearance rates in response to artemether in patients with severe malaria.
    Amaratunga C; Mao S; Sreng S; Suon S; Fairhurst RM
    Lancet Infect Dis; 2013 Feb; 13(2):113-4. PubMed ID: 23347631
    [No Abstract]   [Full Text] [Related]  

  • 30. Artemisinin Therapy for Malaria in Hemoglobinopathies: A Systematic Review.
    Sugiarto SR; Moore BR; Makani J; Davis TME
    Clin Infect Dis; 2018 Feb; 66(5):799-804. PubMed ID: 29370347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naphthoquine phosphate and its combination with artemisinine.
    Wang JY; Cao WC; Shan CQ; Zhang M; Li GF; Ding DB; Shi YL; Wu BA
    Acta Trop; 2004 Feb; 89(3):375-81. PubMed ID: 14744564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are Artemisinin-Based Combination Therapies For Malaria Beginning To Fail in Africa?
    Rosenthal PJ
    Am J Trop Med Hyg; 2021 Sep; 105(4):857-858. PubMed ID: 34491214
    [No Abstract]   [Full Text] [Related]  

  • 33. Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance.
    Jones S; Hodel EM; Sharma R; Kay K; Hastings IM
    J Infect Dis; 2019 Apr; 219(8):1243-1253. PubMed ID: 30517708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed parasite clearance in a splenectomized patient with falciparum malaria who was treated with artemisinin derivatives.
    Le TA; Davis TM; Tran QB; Nguyen VP; Trinh KA
    Clin Infect Dis; 1997 Oct; 25(4):923-5. PubMed ID: 9356813
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic evaluation of the performance of malaria parasite clearance rate metrics.
    Nkhoma SC; Stepniewska K; Nair S; Phyo AP; McGready R; Nosten F; Anderson TJ
    J Infect Dis; 2013 Jul; 208(2):346-50. PubMed ID: 23592863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implicating extracellular vesicles in Plasmodium falciparum artemisinin resistance development.
    Tandoh KZ; Wilson MD; Quashie NB; Duah-Quashie NO
    Traffic; 2021 Jun; 22(6):194-200. PubMed ID: 33860593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia.
    Cutts JC; O'Flaherty K; Zaloumis SG; Ashley EA; Chan JA; Onyamboko MA; Fanello C; Dondorp AM; Day NP; Phyo AP; Dhorda M; Imwong M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Takashima E; Tsuboi T; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJI
    J Infect Dis; 2022 Aug; 226(2):324-331. PubMed ID: 35703955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artemisinin-resistant malaria: research challenges, opportunities, and public health implications.
    Fairhurst RM; Nayyar GML; Breman JG; Hallett R; Vennerstrom JL; Duong S; Ringwald P; Wellems TE; Plowe CV; Dondorp AM
    Am J Trop Med Hyg; 2012 Aug; 87(2):231-241. PubMed ID: 22855752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases.
    Ajayi NA; Ukwaja KN
    Rev Soc Bras Med Trop; 2013; 46(4):525-7. PubMed ID: 23982103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How important is gametocyte clearance after malaria therapy?
    Karunajeewa HA; Mueller I
    BMC Med; 2016 Jun; 14():93. PubMed ID: 27317420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.